RxDoctor Payments Data

Thomas Reilly, MD

Orthopaedic Surgery of the Spine · Kokomo, INNPI 1861597387

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (54.1%), education and food and beverage — rather than concentrated in one kind of arrangement. Globus Medical accounts for 60.2% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $7,035 and has fallen 88.7% since, to $794 in 2025.

$20,120in general payments, 2019–2025

Across 159 payments — averaging $126.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$12K
  • Zimmer Biomet$6K
  • Providence Medical Technology, Inc.$554
  • Medtronic$455
  • Intrinsic Therapeutics$207
  • Johnson & Johnson$131
  • plus $473 from 10 others

What the payments were for

  • Royalty or licence$10,88954%
  • Speaking & faculty fees$90%
  • Food & beverage$3,03215%
  • Education$6,19031%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,120 in reported general payments places this provider in the 55th percentile of 48 orthopaedic surgery of the spine providers in Indiana.

See all orthopaedic surgery of the spine providers in Indiana

Medicare billing

Part B allowed, 2024
$153,281
Medicare patients
191
Services billed
706

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin62$712
Gabapentin70$655
Diclofenac Sodium58$475
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$424
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$188
Tramadol Hcl12$34

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Kokomo

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →